Friday 19 Apr, 2024 06:20 PM
Site map | Locate Us | Login
   HDFC AMC Q4 PAT climbs 44% YoY; recommends dividend of Rs 70/sh    Wipro Q4 PAT rises 5% QoQ to Rs 2,835 cr    Premier Explosives gains as board OKs 1:5 stock split    Hindustan Zinc slides after Q4 PAT decline 21% YoY    Axis Bank board to mull fund raising    Elecon Engg hits record high on strong Q4 outcome, board OKs 1:2 stock split    Jubilant Pharmova Ltd leads losers in 'A' group    Anmol India Ltd leads losers in 'B' group    Volumes soar at TVS Supply Chain Solutions Ltd counter    Information Technology shares slide    Auto stocks edge lower    Real Estate stocks slide    Aurionpro Solutions hits the roof on 67% acquisition in Arya.ai    Canara Bank eases for fifth straight session    Bank of India down for fifth straight session 
Saravan Stocks
       
End - Session
Detailed review of the post market session of the day.
Sensex, Nifty snap 3-day rising streak; pharma shares rally
09-Apr-21   17:08 Hrs IST

The domestic equity benchmarks ended with small losses after a volatile session on Friday. Pharma, IT, FMCG and PSU banks shares advanced. The barometer index, the S&P BSE Sensex, declined 154.89 points or 0.31% to 49,591.32. The Nifty 50 index lost 38.95 points or 0.26% to 14,834.85.

Bajaj Finance (down 3.12%), ICICI Bank (down 1.79%), Reliance Industries (down 1.11%) and HDFC Bank (down 0.83%) were major drags.

In the broader market, the S&P BSE Mid-Cap index slipped 0.08% while the S&P BSE Small-Cap index added 0.69%.

Buyers outnumbered sellers. On the BSE, 1,656 shares rose and 1,249 shares fell. A total of 173 shares were unchanged.

Investors locked profits after a three-day streak. The Sensex rose 1.19% and the Nifty climbed 1.61% in the past three sessions. Rising Covid-19 cases in India also worried investors.

COVID-19 Update:

Total COVID-19 confirmed cases worldwide stood at 13,39,71,287 with 29,02,493 deaths. India reported 9,79,608 active cases of COVID-19 infection and 1,67,642 deaths while 1,19,13,292 patients have been discharged, according to the data from the Ministry of Health and Family Welfare, Government of India.

Ten states including Maharashtra, Chhattisgarh, Karnataka, Uttar Pradesh, Delhi, Madhya Pradesh, Tamil Nadu, Gujarat, Kerala and Punjab have shown a steep rise in the daily COVID-19 cases, accounting for 84.21% of the 1,26,789 new infections, the health ministry said on Thursday. The national weekly COVID-19 positivity rate has increased by 6.21% from 2.19% to 8.40% in the first seven days of March and April, the ministry said.

Numbers To Track:

In the foreign exchange market, the partially convertible rupee fell to 74.73 compared with its previous closing of 74.5875.

The yield on 10-year benchmark federal paper fell to 6.024% as compared to its previous close of 6.031%.

MCX Gold futures for 4 June 2021 settlement shed 0.45% to Rs 46,629.

The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, rose 0.24% to 92.28.

In the commodities market, Brent crude for June 2021 settlement added 1 cent to $63.21 a barrel. The contract gained 0.06% or 4 cents to settle at $63.20 in the previous trading session.

Global Markets:

Most European shares advanced while most Asian stocks declined on Friday. In the US, the S&P 500 rose to another record high on Thursday amid a strong rally in major technology stocks.

Federal Reverse chairman Jerome Powell signaled on Thursday that the economic rebound from the pandemic still has room to go as the recovery thus far hasn't been well-rounded. Powell also repeated that inflation is not expected to be serious even though near-term price pressures are likely.

Data showed an unexpected rise in the number of Americans filing new claims for unemployment benefits. A total of 744,000 Americans filed for unemployment benefits for the first time during the week ended April 3, the Labor Department said Thursday.

Buzzing Indian Segment:

The Nifty Pharma index rose 3.04% to 12,995.35. The index has risen 5.89% so far in April.

Cadila Healthcare (up 10%), Cipla (up 5.34%), Aurobindo Pharma (up 4.47%), Sun Pharmaceutical Industries (up 3.54%), Lupin (up 2.93%), Biocon (up 2%), Dr Reddy's Laboratories (up 1.62%), Torrent Pharmaceuticals (up 1.2%) and Divi's Laboratories (up 0.96%) advanced.

Alkem Laboratories jumped 4.66%. The company's board has approved approved the commencement of commercial production/operations at the Chakan manufacturing facility of Enzene Biosciences, subsidiary of the company, located at Pune, Maharashtra, from 9 April 2021.

Stocks in Spotlight:

IRCTC rose 0.28%. Life Insurance Corporation (LIC) acquired 1.12% in the company in Q4 March 2021. Meanwhile, Indian Railways board chairman Suneet Sharma reportedly said that there are no plans to stop or curtail train services in the country. There is no shortage of trains for those who want to travel, he reportedly said.

Zensar Technologies rose 1.91%. The IT company has entered into a global strategic partnership with US-based Claimatic. The partnership combines industry-leading, decisioning software of Claimatic with Zensar's strategic consulting, enterprise delivery, and implementation services. Zensar said that the new, innovative partnership will leverage the respective strengths of Claimatic and Zensar to create compelling value for both companies and their mutual clients.

Thyrocare Technologies added 3.10%. The company said that Arindam Haldar, who had joined the company as a chief executive officer (CEO) in September 2020, expressed his intention of resigning from his current post for personal reasons.

Larsen & Toubro (L&T) fell 1.06%. The renewables arm of Larsen & Toubro's power transmission & distribution business has secured a turnkey EPC contract, from the consortium of ACWA Power and the Water and Electricity Holding Company (a subsidiary of the Public Investments Fund of Saudi Arabia), for Sudair Solar PV Project of 1.5 GW capacity. According to L&T's classification, the value of the said orders lies between Rs 5,000 crore to Rs 7,000 crore.

Primary Market:

The initial public offer (IPO) of Macrotech Developers received bids for 4.94 crore shares as against 3.64 crore shares on offer, according to the stock exchange data at 17:00 IST on Friday (9 April 2021). The issue was subscribed 1.36 times.

The issue opened for bidding on Wednesday, 7 April 2021, and it will close on Friday, 9 April 2021. The price band for the IPO is set at Rs 483-486 per share.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 32006189
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd